
Suzanne Jansen, MSc, PharmD, ICON, says early-phase clinical success depends on flexible, simple formulations that support wide dose ranges, matching placebos, and robust stability.

Suzanne Jansen is an experienced pharmaceutical professional with a strong background in quality control and clinical research. Currently serving as manager of the QC Laboratory and qualified person (QP) at ICON in the Netherlands, she oversees pharmaceutical analysis and release testing of investigational medicinal products (IMPs), as well as ensures compliance with good manufacturing practice standards. With more than a decade of experience, including 9 years as a pharmacist and QP at ICON’s on-site manufacturing facility, Suzanne has deep expertise in IMP development, manufacturing, and regulatory compliance. She holds a master’s degree in Pharmacy from the University of Groningen.